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Follicular dendritic cell sarcoma (FDCS) is a rare neoplasm; although it is classified under histiocytic and dendritic cell 
neoplasms, FDCS is typically nodal, with extranodal 
involvement occurring in approximately 30% of 
cases.1 The major hurdle in treating FDCS cases 
is misdiagnosis, due to similarities in presentation 
to lymphoma. Cytogenetic data on FDCS are very 
scarce, with the first description appearing in 2008.2,3 
This report presents a FDCS patient with a complex 
karyotype and pathological findings.
Case Report
A 39-year-old woman presented to the Sultan 
Qaboos University Hospital in Muscat, Oman, in 
February 2013 with a swelling on the right side of 
her neck. On examination, a firm, non-mobile, non-
tender supraclavicular swelling was found. Magnetic 
resonance imaging showed a mass involving the 
sternocleidomastoid muscle and the compression 
of the internal jugular vein with an intact carotid 
[Figure 1A].Surgical excision of the tumour revealed 
a globular nodular firm grey mass measuring 7 x 6 x 
2.8 cm [Figure 1B].
For the cytogenetic analysis, a fine needle aspirate 
(FNA) was collected under sterile conditions. The 
FNA was distributed into three culture flasks and 
cultured in Roswell Park Memorial Institute media 
at 37 °C with 5% carbon dioxide. Both 24-hour and 
long-term cultures were set up. When sufficient 
growth was observed under an inverted microscope 
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abstract: Follicular dendritic cell sarcoma (FDCS) is a rare neoplasm with a non-specific and insidious 
presentation further complicated by the difficult diagnostic and therapeutic assessment. It has a low to intermediate 
risk of recurrence and metastasis. Unlike other soft tissue sarcomas or histiocytic and dendritic cell neoplasms, 
cytogenetic studies are very limited in FDCS cases. Although no specific chromosomal marker has yet been 
established, complex aberrations and different ploidy types have been documented. We report the case of a 39-year-
old woman with FDCS who presented to the Sultan Qaboos University Hospital in Muscat, Oman, in February 
2013. Ultrastructural, immunophenotypical and histological findings are reported. In addition, karyotypic findings 
showed deletions of the chromosomes 1p, 3q, 6q, 7q, 8q and 11q. To the best of the authors’ knowledge, these 
have not been reported previously in this tumour. Techniques such as spectral karyotyping may help to better 
characterise chromosomal abnormalities in this type of tumour. 
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امللخ�ص: �ساركومة اخللية التغ�سنية اجلريبية هو ورم نادر تكون اأعرا�سه غري وا�سحة وظهوره قد يكون ب�سورة غري متوقعة. ت�سخي�س 
املر�س يكون �سعبا جدا لعدم وجود طفرة وراثية حمددة ميكن الك�سف عنها عن طريق التنميط النووي و الفحو�سات اجلينية األخرى. يحمل 
هذا املر�س ن�سبة اختطار ب�سيطة اإىل متو�سطة من رجوعه والنقيلة. يختلف هذا الورم عن بقية اأنواع �ساركومة الأن�سجة الرخوية و الأورام 
الن�سيجية والتغ�سنية بقلة فحو�سات الوراثة اخللوية فيه ولكن مت ت�سجيل عدد من الزيغ املعقد و اأنواع خمتلفة من ال�سيغة ال�سبغية لهذا 
املر�س. نعر�س هنا حالة امراأة عمرها 39 عاما مت ت�سخي�سها ب�ساركومة اخللية التغ�سنية اجلريبية يف م�ست�سفى جامعة ال�سلطان قابو�س 
مب�سقط، �سلطنة عمان يف �سهر فرباير من عام 2013، حيث مت االعتماد على التحليل اجلزيئي والفح�س با�ستخدام امل�سادات والت�سخي�س 
مل  للموؤلفني  معرفة  اأف�سل  ح�سب   .1q ،3q ،6q ،7q ،8q و   11q ال�سبغيات،  يف  حذف  وجود  اخللوية  الوراثة  فحو�سات  بينت  الن�سيجي. 
الدقيق للتغريات يف هذة  الت�سخي�س  النووي الطيفي قد متكن من  التنميط  التقنية مثل  الورم. الفحو�سات  يتم عر�س هذا �سابقا يف هذا 
ال�سبغيات.
مفتاح الكلمات: زيغ ال�سبغي؛ الوراثيات اخللوية؛ �ساركومة اخللية التغ�سنية اجلريبية؛ خزعة م�سفوطة بالإبرة؛ التنميط النووي؛ تقرير حالة؛ �سلطنة عمان.
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on the fourth day, 50 µL of colcemid at 10 µL/mL of 
Gibco™ (Life Technologies, Thermo Fisher Scientific 
Corp., Carlsbad, California, USA) was added for 
30 minutes, followed by hypotonic treatment (0.075 M 
of potassium chloride) for 45 minutes. The cell pellet 
was fixed using Carnoy’s fixative solution and slides 
were prepared and G-banded the following day.
Microscopic findings showed a relatively well 
encapsulated neoplasm, composed of nodules 
separated by thick fibrous septae which contained 
multiple foci of lymphoid aggregates. The nodules 
were composed of sheets of pleomorphic spindle 
cells and epithelioid cells with indistinct cytoplasmic 
borders; the nodules exhibited a moderate amount of 
acidophilic cytoplasm, vesicular nuclei and prominent 
nucleoli. These cells were arranged in short fascicles 
or whorls or exhibited a storiform pattern. Abundant 
mitotic figures (24 mitoses/10 high-power fields) and 
apoptotic bodies were present and foci of necrosis and 
haemorrhage were also noted [Figure 2A].
Immunohistochemical staining showed strong 
positivity of neoplastic cells for clusters of different-
iation (CD) 23, CD35 and CD21 via membranous 
staining [Figure 2B] and focal positivity for CD99. 
Markers for CD34, human melanoma black 45 
and CD68 were negative. The Ki-67 protein cell 
proliferation index was high (80%). Electron 
microscopy findings showed elongated nuclei with 
cytoplasmic invagination. Abundant desmosomes 
with no evidence of Birbeck granules were also 
observed [Figure 2C], favouring a diagnosis of FDCS. 
Intranuclear pseudo-inclusions were not visible on 
morphology. The nodular grey tumour mass on the 
sternocleidomastoid muscle compressed the internal 
jugular vein.
Of the 20 karyotypes, 19 showed complex abnor-
mal karyotypes and one showed a normal karyotype. 
The chromosome numbers ranged from 72 to 80. 
Structural aberrations, such as deletions, were observed 
on chromosomes 1p, 3q, 6q, 7q, 8q and 11q. Additional 
material of unknown origin was observed on both 
copies of 16q and 19q. The loss of chromosome 21 
was obvious in the majority of the metaphases. Other 
common missing chromosomes were 8, 9, 13, 14 and 22. 
Various marker chromosomes were present in all of the 
abnormal metaphases. As the range of chromosomes 
were in the hypertriploid category, a composite 
karyotype was interpreted as per the International 
System for Human Cytogenetic Nomenclature (2013).4 








Figure 1A & B: A: Magnetic resonance image showing the follicular dendritic cell sarcoma tumour mass involving the 
sternocleidomastoid muscle. B: Photograph showing a gross specimen of the globular nodular tumour after excision (7 
x 6 x 2.8 cm).
 
Figure 2A–C: Haematoxylin and eosin histopathology 
section showing (A) neoplastic nodules composed 
of sheaths of spindle cells exhibiting vesicular nuclei, 
prominent nucleoli and indistinct cytoplasmic 
borders at x40 magnification, (B) tumour cells showing 
strong membranous positive staining for cluster 
of differentiation 21 at x400 magnification and (C) 
several well-formed desmosomes firmly joining the 
cytoplasmic process of contiguous neoplastic cells at 
x25,000 magnification. This favoured a diagnosis of 
follicular dendritic cell sarcoma.
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current and past experiences with soft tissue sarcomas.8
Immunophenotypic comparisons of the positivity 
of CD21 and CD35 markers vary among patients. In 
the current case, CD21 was strongly positive and the 
tumour cells were also positive for CD23 and CD35; 
similar results were reported by Wang et al. in a 
previous report.6 However, in another report of FDCS 
by Jones et al., all these markers were negative.5 
The current patient had hypertriploidy in all of 
the abnormal metaphases ranging from 72 to 80. 
Earlier reports of FDCS have shown hypodiploidy 
and diploidy in two cases;3,7 furthermore, two cases 
had hyperdiploidy along with pseudodiploidy.5,7 Della 
Porta et al. reported a patient with hypotriploidy and 
Jones et al. reported a patient with hypertetraploidy.5,9 
Notably, two reported cases showed the involvement 
of chromosome Xp.5,7 No involvement of chromosome 
X was observed in the current patient. 
Add(16q) has been reported in previous cases and 
the current patient had similar additional material 
of unknown origin on 16q.3 Add(21q), add(21p), 
add(15p) and add(17p) were reported by Suzuki et 
al., Perry et al. and Jones et al.2,3,5 The patient in the 
current report study also had add(19q) and did not 
have any involvement of chromosomes 14, 15, 17 or 21. 
Marker chromosomes were seen in two earlier cases 
reported by Perry et al., which were also observed 
in the patient in the current report in all of the 
abnormal metaphases.3 
Cytogenetic observations in the current patient 
showed novel aberrations, such as the deletion of 
chromosomes 1p, 3q, 6q, 7q, 8q and 11q, which were 
not reported earlier [Table 1]. These novel findings are 
an addition to the literature already available on FDCS. 
Material of unknown origin was observed in both 
copies of chromosome 16 and 19 in the current patient, 
in contrast to the gains observed in earlier reports 
Although FDCS is pathologically well characterised, 
there are very few cases described cytogenetically. 
Thus far, only six case reports are available in the 
literature with chromosomal findings.2,3–7 To the 
best of the authors’ knowledge, this is the first report 
from a Middle Eastern Arab population. The results 
of the current case yielded a good mitotic index and 
morphology of chromosomes by culturing the FNA 
of the tumour, which is often difficult to obtain. In 
sarcomas, even though the cytology of FNA material 
may not be of much diagnostic use, the cytogenetic 
benefits are substantial.6 Hence, the authors of this 
report endorse FNA as the best technique for obtaining 
ideal samples for solid tumour cytogenetics, as per 
 
Figure 3A & B: Representative complex karyotypes showing structural abnormalities such as del(1p), del(3q), del(6q), 
del(7q), del(8q), del(11q), add(16q) and marker chromosomes in a patient with follicular dendritic cell sarcoma.
Table 1: Comparative analysis of the ploidy status, 
frequently involved chromosomes and structural 
aberrations in follicular dendritic sarcoma cases in 
the literature
Author 


























Wang et al.6 
2010
Diploidy (46) Normal 
karyotype
Perry et al.3 
2013
Hypodiploidy 15p+, 16q+, 
17p+
Present case Hypertriploidy (72–80) 1p-,3q-, 6q-, 
7q-, 11q-, 
16q+, 19q+
Follicular Dendritic Cell Sarcoma 
Cytogenetics and pathological findings
e414 | SQU Medical Journal, August 2015, Volume 15, Issue 3
for chromosomes 3, 7, 8 and 9.7 Hence, observations 
from the current patient confirm the heterogeneity 
of chromosomal findings in FDCS proposed by Perry 
et al. in their two cases.3 
Great variation has been observed among the 
ploidy statuses and structural alterations in FDCS 
cases. Use of the latest technologies, such as spectral 
karyotyping, is recommended for the complete 
characterisation of chromosomes. Single nucleotide 
polymorphism arrays and next generation sequencing 
should also be utilised in future studies investigating 
the genes responsible for FDCS. 
Conclusion
FDCS is a rare tumour which is difficult to diagnose 
based on its non-specific presentation. Unlike other 
soft tissue sarcomas, cytogenetic studies are very 
limited in FDCS cases. Cytogenetic observations of the 
current patient with FDCS showed novel aberrations, 
such as the deletion of chromosomes 1p, 3q, 6q, 7q, 
8q and 11q; to the best of the authors’ knowledge, 
these have not yet been reported. The cytogenetic 
characterisation of rare tumours is important so 
as to establish chromosomal markers. This aids 
in the diagnosis of patients and enables a precise 
classification in order to predict prognosis. However, 
further research is needed before a conclusion can 
be drawn. Spectral karyotyping is recommended for 
the complete characterisation of chromosomes for 
this type of tumour. Moreover, FNA is deemed the 
best technique for obtaining samples for cytogenetic 
analyses of solid tumours.
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